Skip to main content

Table 5 Comparison between cases with and without MS as regards SBP, serum TGs, and CIMT

From: Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk

Variable Cases with MS Cases without MS p
  (n = 18) (n = 42)  
TGs (mg/dl) 143.9 ± 29.4 116 ± 25.8 0.028
SBP (mmHg) 137.22 ± 6.18 127.14 ± 10.316 < 0.0
CIMT (mm) 0.9 ± 0.1 0.67 ± 0.09 < 0.01
NAFLD-LFS 1.19 (− 0.5 to 2.57) − 1.245 (− 1.8 to 1.27) < 0.01*
  1. MS metabolic syndrome, SBP systolic blood pressure, TGs triglycerides, CIMT carotid intima-media thickness, NAFLD-LFS non-alcoholic fatty liver disease-liver fibrosis score
  2. *Mann-Whitney (z) test